Gino Ussi serves as the President of Corporate Markets at Elsevier, where he spearheads the global Corporate Markets organization, encompassing the Life Sciences, Engineering, and Global Pharma sectors. With a robust background in the business information industry, Gino is adept at navigating complex business models...
Gino Ussi serves as the President of Corporate Markets at Elsevier, where he spearheads the global Corporate Markets organization, encompassing the Life Sciences, Engineering, and Global Pharma sectors. With a robust background in the business information industry, Gino is adept at navigating complex business models characterized by high operational gearing and leveraging opportunities for organic revenue growth. His strategic acumen is evident in his leadership of key projects that drive profitability and enhance shareholder value, ensuring that the organization remains at the forefront of innovation in a rapidly evolving marketplace.
Under Gino's guidance, the Corporate Markets division has successfully implemented initiatives focused on P&L management and budgeting, optimizing operational efficiencies while maintaining a keen eye on sales capacity and productivity growth. His expertise in acquisitions and integration has proven invaluable, allowing Elsevier to expand its market reach and enhance its service offerings. Gino is also committed to fostering a culture of leadership development, equipping his teams with the skills necessary to lead change effectively and adapt to shifting market dynamics.
In addition to his operational leadership, Gino excels in strategic planning and execution, utilizing competitive analysis and market research to inform business strategy. His comprehensive understanding of organizational restructuring enables him to streamline processes and drive performance improvements across the organization. As a result, Gino Ussi not only enhances the operational capabilities of Elsevier's Corporate Markets but also positions the company as a leader in delivering high-value solutions to its clients in the Life Sciences, Engineering, and Global Pharma sectors.
